Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer

NCT00003257 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: Ad5CMV-p53 gene

Sponsor

Aventis Pharmaceuticals